KospicyKorean filings in English
Filings / Celltrion Pharm

Preliminary Operating Results (Fair Disclosure)

Celltrion Pharm · 영업(잠정)실적(공정공시)

8-KKOSDAQ · 068760 Filed 2026-11-09Korean original on DART

English form view 59% translated

Translated from a fixed dictionaryLeft in Korean (free text, names)Numbers and dates are copied unchanged

Preliminary Operating Results (Fair Disclosure)

Results Period
Current Period Results2026-07-01~2026-09-30
Prior Period Results2026-04-01~2026-06-30
Prior-Year Same Period Results2025-07-01~2025-09-30
Current Period Cumulative Results2026-01-01~2026-09-30
Prior-Year Same Period Cumulative Results2025-01-01~2025-09-30
※ 당해 정보는 확정치가 아닌 잠정치로 결산 결과 등에 따라 변경될 수 있음.
1. Performance Details
Category (Unit: KRW m, %)Current Period ResultsPrior Period Resultsvs. Prior PeriodPrior-Year Same Period ResultsYoY
(26.3Q)(26.2Q)Change (%)Profit/loss turnaround(25.3Q)Change (%)Profit/loss turnaround
RevenueCurrent Results161,874153,2915.60-138,17517.15-
Cumulative Results447,287---381,99617.09-
Operating IncomeCurrent Results23,90119,30623.80-16,10848.38-
Cumulative Results56,108---42,36732.43-
Income from continuing operations before income taxCurrent Results23,51518,51826.99-15,12455.49-
Cumulative Results53,869---39,21437.37-
Net IncomeCurrent Results17,67113,72128.79-11,45954.21-
Cumulative Results40,210---29,86934.62-
--------
2. Information ProvidedInformation Provider(주)셀트리온제약 경영관리팀
Information Recipient기관, 일반투자자, 증권사 및 언론사 등
Information release date (scheduled)After Fair Disclosure
Information release time (scheduled)-
Event Name (Venue)-
3. ContactChief Disclosure Officer (Name)박성준 상무
Chief Disclosure Officer (Phone)070-8675-7681
Disclosure Officer (Name)최시영 대리
Disclosure Officer (Phone)070-8675-7681
Department Name경영관리팀
Department (Phone)070-8675-7681
4. Other Matters Relevant to Investment Decisions- 상기 실적은 한국채택국제회계기준(K-IFRS)에 따라 작성된 개별재무제표 기준 영업(잠정) 실적입니다. - 상기 실적은 외부감사인의 회계감사가 완료되기 이전의 내부결산 자료로 감사결과에 따라 변경될 수 있습니다.
Related Disclosures-